Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Rozenbaum MH, Huang L, Perdrizet J, Cane A, et al. Vaccine 2024 Jan 7:S0264-410X(23)01503-7. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Rozenbaum MH, Huang L, Perdrizet J, Cane A, et al. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Vaccine 2024 Jan 7:S0264-410X(23)01503-7. doi: 10.1016/j.vaccine.2023.
PMID: 38191278